Cargando…
Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses
When developing drugs against SARS-CoV-2, it is important to consider the characteristics of patients with different co-morbidities. People infected with HIV-1 are a particularly vulnerable group, as they may be at a higher risk than the general population of contracting COVID-19 with clinical compl...
Autores principales: | Fomenko, Vladislav V., Rudometova, Nadezhda B., Yarovaya, Olga I., Rogachev, Artem D., Fando, Anastasia A., Zaykovskaya, Anna V., Komarova, Nina I., Shcherbakov, Dmitry N., Pyankov, Oleg V., Pokrovsky, Andrey G., Karpenko, Larisa I., Maksyutov, Rinat A., Salakhutdinov, Nariman F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746574/ https://www.ncbi.nlm.nih.gov/pubmed/35011529 http://dx.doi.org/10.3390/molecules27010295 |
Ejemplares similares
-
(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Filimonov, Aleksandr S., et al.
Publicado: (2022) -
Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Yarovaya, Olga I., et al.
Publicado: (2022) -
Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights
por: Borisevich, Sophia S., et al.
Publicado: (2022) -
Synthesis and Antiviral Activity of Camphene Derivatives against Different Types of Viruses
por: Sokolova, Anastasiya S., et al.
Publicado: (2021) -
Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
por: Borisevich, Sophia S., et al.
Publicado: (2023)